Dana-Farber Cancer Institute (DFCI)
United States of America (USA)
1 May 2020 - 1 April 2021
Parent institution: Harvard University
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Dana-Farber Cancer Institute (DFCI) published between 1 May 2020 - 1 April 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 501 | 60.57 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Physical Sciences | 44 | 2.66 | |
| Life Sciences | 457 | 57.45 | |
| Chemistry | 45 | 7.13 | |
| Earth & Environmental Sciences | 1 | 0.01 | |
Top articles by Altmetric score in current window
Affiliated joint institutions and consortia
- ASAN Center for Cancer Genome Discovery (ASAN-CCGD), South Korea
- CLL Research Consortium (CRC), United States of America (USA)
- Center for Cancer Systems Biology (CCSB), United States of America (USA)
- Center for Molecular Imaging Research (CMIR), United States of America (USA)
- Children's Oncology Group (COG), United States of America (USA)
- Clinical Sequencing Exploratory Research (CSER), United States of America (USA)
- Collaboration for AIDS Vaccine Discovery (CAVD), United States of America (USA)
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, United States of America (USA)
- Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), United States of America (USA)
- Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE), United States of America (USA)
- Hansjorg Wyss Institute for Biologically Inspired Engineering, United States of America (USA)
- Harvard Stem Cell Institute (HSCI), United States of America (USA)
- ICGC Breast Cancer Project: Triple Negative/Lobular/Other, United Kingdom (UK)
- ImmGen Consortium, United States of America (USA)
- Joint Center for Cancer Precision Medicine, United States of America (USA)
- Massachusetts Consortium on Pathogen Readiness (MASSCPR), United States of America (USA)
- Multiple Myeloma Research Consortium (MMRC), United States of America (USA)
- Parker Institute for Cancer Immunotherapy, United States of America (USA)
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
